miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer

Published:2016-11-14 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Chen Jiawei,Shin Vivian Y.,Siu Man T.,Ho John C. W.,Cheuk Isabella,Kwong Ava

Funder

Dr Ellen Li Charitable Foundation

Kerry Kuok Foundation

Hong Kong Hereditary Breast Cancer Family Registry

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2916-7.pdf

Reference43 articles.

1. Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011;223(2):307–17.

2. Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011;121(10):3786–8.

3. Pogoda K, Niwinska A, Murawska M, Pienkowski T. Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Med Oncol. 2013;30(1):388.

4. Ranganathan K, Sivasankar V. MicroRNAs - Biology and clinical applications. J Oral Maxillofac Pathol. 2014;18(2):229–34.

5. McClelland AD, Kantharidis P. microRNA in the development of diabetic complications. Clin Sci. 2014;126(2):95–110.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet-derived microvesicles isolated from type-2 diabetes mellitus patients harbour an altered miRNA signature and drive MDA-MB-231 triple-negative breast cancer cell invasion;PLOS ONE;2024-06-20

2. Functional roles of microRNAs in vasculogenic mimicry and resistance to therapy in human cancers: an update;Expert Review of Clinical Immunology;2024-05-09

3. Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer;Advanced Therapeutics;2024-03-25

4. Role of miRNA 199a-5p Expression in Iraqi Women with Breast Cancer;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2023-11-04

5. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA;International Journal of Molecular Sciences;2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3